The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies

The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies

Background: Alzheimer’s disease (AD)-related pathology is frequently found in patients with dementia with Lewy bodies (DLB). However, it is unknown how amyloid-β and tau-related pathologies influence neurodegeneration in DLB. Understanding the mechanisms underlying brain atrophy in DLB can improve o...

Full description

Bibliographic Details
Main Authors: Carla Abdelnour, Daniel Ferreira, Ketil Oppedal, Lena Cavallin, Olivier Bousiges, Lars Olof Wahlund, Jakub Hort, Zuzana Nedelska, Alessandro Padovani, Andrea Pilotto, Laura Bonanni, Milica G. Kramberger, Mercè Boada, Eric Westman, Javier Pagonabarraga, Jaime Kulisevsky, Frédéric Blanc, Dag Aarsland
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:NeuroImage: Clinical
Subjects:
Lewy body disease
Biomarkers
Atrophy
Alzheimer disease
Neuroimaging
Online Access:http://www.sciencedirect.com/science/article/pii/S2213158220301704

Internet

http://www.sciencedirect.com/science/article/pii/S2213158220301704

Similar Items